Public Release: 

Study examines polyneuropathy and long-term opioid use

The JAMA Network Journals

Polyneuropathy is a common painful condition, especially among older patients, which can result in functional impairment.

In a new article published by JAMA Neurology, Christopher J. Klein, M.D., and his colleagues at the Mayo Clinic, Rochester, Minn., examined the association of long-term opioid therapy with functional status, adverse outcomes and death among patients with polyneuropathy. The population-based study included data from 1,993 patients with polyneuropathy who were receiving opioid therapy and a group of control patients for comparison.

Polyneuropathy was associated with an increased likelihood of long-term opioid therapy of 90 days or more.

Those patients receiving long-term opioid therapy also were more likely to be diagnosed with depression, opioid dependence or opioid overdose. Self-reported functional status measures were either unimproved or poorer among those patients receiving long-term opioid therapy, according to the results.

Limitations of the study include that it was based on prescription data without confirmation that prescriptions were filled and taken as intended.

"Polyneuropathy increased the likelihood of long-term opioid therapy. Chronic pain itself cannot be ruled out as a source of worsened functional status among patients receiving long-term opioid therapy. However, long-term opioid therapy did not improve functional status but rather was associated with a higher risk of subsequent opioid dependency and overdose," the article concludes.

###

For more details and to read the full study, please visit the For The Media website.

(doi:10.1001/jamaneurol.2017.0486)

Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Related material: The editorial, "Lack of Evidence for Benefit From Long-term Use of Opioid Analgesics for Patients with Neuropathy," by Nora D. Volkow, M.D., and Walter Koroshetz, M.D., of the National Institutes of Health, Bethesda, Md., also is available on the For The Media website.

To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2017.0486

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.